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In this article we present a new diagnostic approach utilizing flow-cytometry to study compounds of nanopar-
ticle samples in solution by analysis of their scattering patterns retrieved from the cytometric measurements.
As a specific enhancement of this technique we study as well the scattering pattern of nanoparticles in a
fluorescent solution (529 nm). A significant enhancement of the cytometry measurements is observed sup-
porting an improved separation of particle formations that are clearly resolved in the cytograms. The samples
in this experiment are prepared from 80 nm citrate-capped gold nanoparticles (AuNP). They are stabilized
providing 2-(dimethylamino)ethanol (DMAE) in the aqueous solution. A laser diode with a wavelength of
488 nm is used as fundamental illumination for the flow-cytometry measurements (FCM). Dynamic Light
Scattering (DLS) measurements are performed separately and demonstrate a very good agreement with the
Flow-Cytometry measurements both of which allow to give an effective size calibration. For further analysis
light transport simulations are presented. They provide information on the key-process to form the correlation
of the fluorescent solutions FCM to the studied particles of interest. From this we extract the volume nature
of the scattering process ensuring the correlation.
I. INTRODUCTION
Current microbial studies drive innovative develop-
ments leading to various clinical and microbiological di-
agnostic applications like flow cytometry1,2,31 which is
of particular interest for the new approach followed in
this article. Since the development of flow cytometry
with the first apparatus in 196520 these devices were con-
stantly developed to feature diagnostic applications with
increasing performance.
Cell diagnostics analysing forward and sideward op-
tical scattering properties are established by flow-
cytometry techniques without any staining of the sam-
ple solutions. This gives rise to developments of func-
tional staining reactants and fluorescent detection tech-
niques to address scientific questions with respect to cell-
activity and -vitality. In particular investigating the cell
esterase activity is driving research from the beginning
of these apparative and functional improvements26 in
cytometry techniques and is still a major topic of re-
cent scientific and clinical interest5,14. According to the
new insights arising from nano applications in medicine
this technique is of increasing interest with respect to
the optical properties of tailored nanoparticles in medi-
cal applications. This faces new developments in Flow-
Cytometry (FCM) for different types of applications. As
a brief overview fast automated cell sorting17, in vivo5,8,
imaging3 and real-time flowcytometry28,31 techniques are
already utilized to perform specific tumor cell medical
studies6,9,13,23,24,30. Besides other topics in the appli-
cation of Nanoparticles (NP) in medical applications,
Nanoparticle assisted diagnostic and therapy approaches
provide a huge variety of FCM applications for cancer-
and stem cell research. Plasmonic enhancement is al-
ready a key technique to improve material contrast6,18,22
in diagnostic and therapeutic fields and could be used in
FCM as well. Localized excitation of gold (Au) NPs en-
ables transport of anticancer drugs6,13,24,30, where the
cellular specific reception is precisely specified by the
parameter space extracted from flow-cytometry23,24,30
measurements. To our best knowledge current research
and the related therapy approaches of this kind are
still necessarily combined with a fluorescence labelling
of the AuNPs. Especially multiple cell targeting4 uti-
lizing AuNPs is limited by this cell specific labelling.
Thus FCM applications are usually confined on the con-
ventional cell stained vitality9 or the cell specific recep-
tion quantifications23,24,30. In this article we present a
novel FCM scheme, where no fluorescent labelling of the
AuNPs is needed at all. We demonstrate that our specific
amendments do not change the standard process of FCM
but can significantly enhance the amount of information
gathered from these measurements.
Therefore, our approach focuses on the utilization of
localized ambient illumination of the nanoparticle in so-
lution. This diffuse illumination originates from fluores-
cent emission of the solvent medium on a molecular scale
which we call a volume illumination effect further on. As
a consequence the response of the investigated particles is
a localized light scattering information inside the volume.
This response provides additional and so far untouched
information gathered by Flow-Cytometry especially in
the sideward detection direction. We demonstrate that
plasmonic enhancement improves the contrast separat-
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2ing the particle scattering from solvent ambient emis-
sions even under presence of a massive unspecific scat-
tering background. The nature of volume light transport
associates the particle scattering response to the local-
ized ambient fluorescent excitation apart from the diffuse
emission.
We can clearly resolve an enhanced particle response
in the sideward scattering signature, which can be de-
tected with fluorescent flow-cytometry (FL/FSC). In the
following we discuss an improved specificity for the de-
tection of the particle of interest which can lead to new
applications investigating unspecific and unknown sam-
ple solutions in terms of plasmonic enhanced solutions
without the necessity of fluorescent labelling of the parti-
cles themselves. We emphasize that for all measurements
presented in the following not fluorescent labelling of a
particle was existing or initiated. Only the ambient il-
lumination in the solution is supported by a fluorescent
excitation at 529 nm caused by the DMAE assisted re-
actions with the solvent medium. For a more extended
study of this new technique we force agglomeration of the
particles changing the solvent environment by addition of
NaCl (aqueous, 0.9 %) into the stabilized solutions. The
flow-cytometric studied samples are characterized by Dy-
namic Light Scattering (DLS) in more detail. A charac-
terization of these localized particle formations is only
discussed briefly based on the FL/FSC Flow-Cytometry
observations. In addition to this new approach in FCM,
FTIR studies are performed in solutions of the DMAE
stabilized citrate-capped AuNPs. For the FTIR measure-
ments a fluorescein based labelling of the compounds is
prepared to determine whether such labellings are inhib-
ited by the provided amine surplus (1.7 mM, DMAE).
These measurements show that a stimulated labelling is
prevented, if the nanoparticle solutions are not forced to
agglomerate.
II. EXPERIMENT
A. Material and Methods
1. Preparation
Citrate capped gold nanoparticles in aqueous solu-
tion are stabilized providing 2-(dimethylamino)ethanol
(DMAE) at 50◦C (oil-bath) temperature under Ar at-
mosphere. Solutions were stirred at this temperature for
90 minutes.
The chemical reduction driven due to the protonation of
the tertiary amine Nitrogen functionality is performed at
a low concentration level of 0.17 mM of DMAE and a
reaction proceeding in the presence of 1.7 mM of DMAE
is performed to obtain a mono-disperse sample solution.
Agglomerated samples are prepared by a provoked charg-
ing of the amine stabilized particle solution by adding
aqueous NaCl (80 mM). A negative control is prepared
repeating the procedure by use of 1.7 mM of DMAE
agent in absence of the gold particles. For the negative
control sample the nanoparticle solution is replaced by
ultra-pure water (Millipore).
All glassware is cleaned with ultra-dry (alkali metals
processed) ethanol and dried at 120 ◦C for 15 minutes.
All reactants are added under Schlenk conditions. The
gold nanoparticles (CANdots Series G, 0.1 mg/ml) are
used in aqueous solutions as purchased (CAN GmbH,
Hamburg, Germany). These solutions were degassed sev-
eral times before adding the DMAE agent. The solvent
amount of the purchased particles is retained in spite of
a dilution in the case of the mono-disperse reference sam-
ple. The NaCl is added as 0.9% aqueous solution.
2. Flow-Cytometry
Measurements are performed with a CyFlow Space
(Partec, PMU) Flow-Cytometer. The fundamental ex-
citation and illumination wavelength is 488(±2) nm
(50mW, laser diode). The sideward detection is real-
ized by a x50 objective lens (NA 0.82, WD 0.4 mm) for
collimation. The fluorescent response from scattering in
the sample solutions are analysed in sideward detection
(SSC) passing interferometric optical filters (536/40 nm
and a 488/6 nm). The detector gains are adjusted to be
x2.4 - (at fluorescence, FL) and x0.8 (sideward scatter-
ing, SSC ) with respect to the forward detection (FSC).
The FL and SSC flow-cytometry measurements are per-
formed simultaneously.
B. Procedure
1. Colocalization Analysis
The cytograms are recorded as histograms with 12-bit
(4096 x 4096 channels) resolution. They are analysed
performing a 2-dimensional correlation analysis. Den-
sity plots are generated with a scaling to 400 x 400 bins
(no interpolation). The colocalization cytogram plots are
retrieved comparing the SSC/FSC and the FL/FSC bi-
variable density data. This analysis is performed using
a ’RG2B Colocalization’ code.12,25,29 The FL/FSC to
SSC/FSC cytograms colocalizations are scaled to exploit
the 8-bit pseudo-color scale, respectively. The event axes
in all cytogram plots are presented as measured and are
scaled in units of ”thousand” channels.
2. Volume scattering calculations
Light transport simulations are performed based on
Monte-Carlo (MC) calculations. The volume scattering
functions are shaped by Henyey-Greenstein (HG)7,11,21
analytical phases. The defuse fluorescence is supposed
to be caused by isotropic scattering events (HG, g=0),
where the scattering in the sample cell volume is
3Figure 1. Cytograms of DMAE reduced citrate-capped AuNP
solutions: Reactions in presence of 1.7 mM of DMAE (a, b, c) in
a direct comparison to a poly-disperse formation due to charged
capping provoked agglomeration, when adding 0.9% of NaCl (d, e,
f). Colocalization plot (a, d), fluorescence cytograms (b, e) and of
the pure scattering measurement (c, f), respectively.
introduced by using a g=0.64 (forward/backward)
anisotropy parameter. As the coefficient of attenuation
by scattering a value of µs=139.861 1/cm is used. This
value is assigned to the scattering events and is retrieved
from MIE-calculations, where an effective concentration
of three primary gold nanoparticles (80 nm) per cubic
micron is assumed. The HG anisotropy factor g is
obtained by stimulated agglomeration to effective sizes
of 1830 nm and used to estimate the optical scattering
parameters in the pre-calculations. In all calculations
aqueous solutions are assumed. The optical refractive
indices in MIE-calculation are obtained from19, where
the real one of the medium (supposed to be pure water
here) is used from10.
The sample volume cell used in the volume light trans-
port simulations is defined by a 3-dimensional mesh of
444x444x444. With these simulations both cases model
scattering events, thus the volume fluorescence (g=0) and
fundamental scattering (g=0.64) can be compared. The
dimensions of the model cell is given by a cube of 7.4 µm
length. The walls are set to support no further boundary
condition. A radial symmetry is supposed averaging over
transversal directions. To cover the cell volume most ef-
ficiently the transport simulation has been repeated six
times. The initial trajectories at the illuminating spot are
randomly distributed. About 13-24 thousand photons
per iteration are simulated in the g=0.64 (scattering)
and 18-32 thousand photons per iteration are simulated
in the g=0 (isotropic, fluorescence). A detailed view of
the modeled cell spanning a region of 1.3 µm x 1.3 µm
and 0.65 µm (in propagation direction) is observed to
cover all trajectories information, which does not vanish
after averaging over six iterations with (8-bit) resolution.
The illumination is limited to a size of 1 µm (Gaussian
and placed 0.03 µm behind the entrance surface. The
MC calculations are performed by using a light transport
simulation algorithm15,16,21,27, which basically yields flu-
ence normalized to the total throughput. The forward
propagated relative flux rates obtained are converted to
logarithmic scaled measurements of attenuation giving
an impression of their spatial distributions as they differ
for the volume fluorescence and the volume scattering
events.
The retrieved maps of attenuation by fluorescence or by
scattering caused from the investigated localized parti-
cle formation are analysed with respect to the sideward
direction. This direction corresponds to the direction of
the flow-cytometry measurements.
The simulations are aimed to get an idea, whether scat-
tering caused by quasi localized particles in solution af-
fects the cytometric detectable response of the sample
solution in a sufficient way, to provide significant dissim-
ilarities to a pure and diffuse volume fluorescence.
III. RESULTS AND DISCUSSION
A. Flow-Cytometry
After the amine reduction by chemical preparation the
citrate capped AuNP solutions (primary particle size
about 80 nm) are investigated in a Flow Cytometry
setup. The samples are studied in fundamental (488 nm)
scattering cytogram (SSC/FSC) acquisition.
The results are compared to the fluorescence detection
measurements (FL/FSC). A FL (529 nm) specific detec-
tion is ensured by the utilized optical filter. A spectral
interference of fundamental scattering and fluorescence
is strictly avoided with respect to the spectral character-
istics of the interference filters (488/6 and 536/40) used
in sideward detection.
Fig. 1 shows an analysis of correlations (Fig. 1a) for the
1.7 mM stabilized AuNP solution , the FL/FSC (Fig.
1b) and the SSC/FSC cytograms (Fig. 1c)of an agglom-
erated sample solution (see Fig. 1d, e, f). The false-colors
of the correlation cytogram plots correspond to the ratios
of colocalization of the analysed FL/FSC and SSC/FSC
measurements, respectively. Both of these measurements
are analysed with respect to colocalizations in the equally
scaled fluorescence and scattering cytogram plots. The
scattering and fluorescence cytograms are presented as
4density plots. The event axes are scaled by 1/1000 with
respect to the measured channels (12-bit resolution).
For the 1.7 mM DMAE AuNP sample solution a sin-
gle feature is observed in the SSC/FSC cytogram (Fig.
1c). It is slightly tilted with an angle of 3-4 deg. A sig-
nificantly enhanced separation from the cytogram back-
ground is obtained from the corresponding FL/FSC (b)
measurement in contrast to the conventional fundamen-
tal scattering SSC/FSC (c). An unspecific scattering
background is found to interfere with the SSC measure-
ment.
The 1.7 mM DMAE AuNP sample solution is analyzed
to be highly monodisperse with respect to the FL mea-
surement.
The feature, which is associated to the corresponding for-
mation of particles in solution, is localized at about 1.74
(FSC -axis projection). This is retrieved to be colocalized
in both of the measurements, the SSC and the FL de-
tection (compare a)). A detailed analysis of dispersities
of the compared sample solutions is presented later. In
the right side panel of Fig. 1 d, e, f the same measure-
ments but with agglomerated AuNP solution are shown
and compared to the monodisperse AuNP sample.
As for the monodisperse sample solution the FL de-
tection cytogram measurements (e) show a clearly im-
proved separation from the cytogram background for the
agglomerated AuNP sample. The agglomeration of the
AuNPs is found at a FSC 1.9-2.2 localized feature in our
measurements. A weaker 1.7 FSC remaining feature is
re-established in the analysis of both the FL and SSC de-
tection, when their colocalizations in the cytogram plots
are analyzed. The colocalization plot is shown in Fig.1d.
It is presented in comparison to the corresponding plot of
the measurements of the stabilized monodisperse sample
solution (see the counterpart left panel a)). In addition
to the FSC 1.9-2.2 feature (Fig. 1d) the agglomerated
particles in the NaCl enriched solution appears in a in-
creased tilt of the SSC cytogram measurement (Fig. 1f).
It is found to be 7-8 deg in contrast to the 3-4 deg for
the stabilized sample.
This already gives a first information on the corre-
sponding agglomerated sizes. The increase of the tilt
towards the diagonal of the feature at FSC 1.9-2.2 in
the SSC/FSC plot can be directly associated to the for-
mation of bigger agglomerates. The effective sizes of the
agglomerates are still in a regime where the scattering
events are not dominated by elastic optical scattering
since elastic scattering driven cytogram measurement
would show a distinct alignment of the respective size
associated features along the diagonal of the SSC/FSC
plot.
In Fig. 2a a detailed analysis of the cytogram mea-
surements is given. Profiles obtained by averaging along
the colocalizations axis of the measurements (Fig1a,d)
are presented as they are obtained from the FL to SSC
colocalization analysis plots.
An additional measurement for a very low DMAE
(0.17 mM concentration AuNP sample solution) is given
for comparative reasons in this diagram. All profiles
retrieved are analyzed performing fits based on Gaussian
profiles. The profiles of all the three sample types are
shown with the corresponding fit.
From the fit of the profiles associated to the cytometry
measurements of the 1.7 mM DMAE stabilized sample
we can see that this solution is verified to show a high
degree of mono-dispersity (see orange curve). No fur-
ther feature apart from the one localized at 1.726±0.002
FSC (”A”) is observed. The width of this feature is
found to be 0.301±0.003 (FSC). For the forced agglom-
eration (blue curve) the dispersity turns out to show a
more complex situation. The associated colocalization
cytogram profile is matched by a 4-components fit. In
addition to the feature ”A”, which is still present, ad-
ditional features localized at 1.966±0.006 FSC (”B”)
and 2.184±0.008 FSC (”C”) and a further component
at 1.328±0.004 FSC show up.
It is pointed out here, that there is no cytogram com-
ponent observed in the region of the 1.328 FSC, if the
solution is stabilized by the 1.7 mM DMAE. This com-
ponent is found to turn up in the 0.17 mM DMAE AuNP
sample (dark-green curve) as well as the component ”B”.
A further feature is localized at 2.296±0.018 FSC. It
is observed to be slightly shifted with respect to ”C”.
An additional component at 2.805±0.038 is associated
to the feature of the highest FSC projection value for the
very low DMAE concentration solution.
Additional MIE-calculations are performed to support
the evidence of a plasmonic resonance enhancement as
it occurs in our cytometry configuration for all measure-
ments at 488 nm excitation. For effective particle sizes
up-to 225-300 nm a plasmonic enhancement of all cy-
tometry measurements is rectified if the effective particle
formations have sizes smaller than this (see ESI).
To verify the 1.328 FSC feature measured in the ag-
glomerated sample a particle size characterization of the
particle solutions by Dynamic Light Scattering (DLS) is
performed. The measurements are shown in Fig. 2b.
The 1.7 mM DMAE stabilized solution (orange) and
the low concentration 0.17 mM modified solution (dark
green) as well as a negative control containing no par-
ticles (light gray) are measured. The recorded correla-
tion time-traces are analyzed by a multi-component fit-
ting procedure. Relaxation rates are extracted from this
analysis of the DLS measurements. The hydrodynamic
sizes in diameter are calculated from the translation dif-
fusion coefficients. Fitting for the agglomerated sample
(blue curve) was not possible due to the low correlation
time-trace quality of the measurement.
The DLS measurements were recorded under 173 deg
and therefore a backscattering configuration utilizing an
illuminating laser wavelength of 632 nm is used. This
configuration serves for a sufficient scattering signal for
our aqueous sample solution, if the containing AuNP
formation shows effective sizes smaller than 300 nm.
5Figure 2. Fraction analysis (a) of DMAE reduced citrate-capped
AuNP solutions: 0.17 mM DMAE stabilized (blue), 1.7 mM DMAE
stabilized (orange) and the 0.9% NaCl added agglomeration control
one (red). Calibration DLS measurements (b): 0.17 mM DMAE
stabilized (blue), 1.7 mM DMAE stabilized (orange), negative con-
trol (no AuNPs) (grey) and the corresponding fits (dashed).
(see blue curve obtained from the MIE-calculations,
ESI2).
Nevertheless, the hydrodynamic sizes retrieved from the
DLS measurements of our sample solutions are in good
agreement with the results from the flow-cytometry
colocalization plots.
Thus, the feature ”A” and therefore the monodisperse
sample solution is nicely matched to an effective hydro-
dynamic size of 93.5±10.3 nm from the DLS calibration
measurement.
The components associated to the mean sizes of the
particle formations in our sample solutions retrieved
from DLS are assigned to the observed cytogram fea-
tures. Different sensitivities with respect to the sizes of
contributing particle formation in the cytometry and
the DLS measurements are deduced from the performed
MIE calculations (see the red and blue curves in ESI2).
The sub-dimer effective size associated to the 1.7 mM
solution component ”A” represents an agglomeration of
less than two NPs and is even valid for multicomponent
fitting analysis of the corresponding DLS measurement.
Features (”A”,”B”,”C”) as they are revealed from
the colocalization analyzed cytometry measurements
(1.726 FSC, 1.966 FCS and 2.184 FCS projection) of
our AuNP sample solutions are matched to the DLS
compounds and their effective hydrodynamic sizes (94
nm, 102 nm and 180 nm), respectively. In addition
to the compound ”A”, which is reproduced with lower
intensity in the agglomerated AuNPs solution cytometry
measurements, two further compounds are associated to
the common cytogram features from the agglomerated
and the 0.17 mM modified solution.
These compounds ”B” and ”C” are successfully
matched to the correlation measured in the DLS traces
for the 0.17 mM DMAE modified sample. Compound
”C” is strongly influenced by the scattering background
of the DLS measurement of this sample caused by the
medium. This is related to the complexity of the impure
AuNP solutions and the reduced scattering efficiency of
bigger agglomerates.
Following the corresponding time trace from the DLS
measurements at values above roughly 100 ms for the
0.17 mM DMAE modified solution a single component
fit model is used. It is associated to any bigger agglom-
erated compounds with effective sizes ¿300 nm. These
are subsumed with a component ”D” associated with a
hydrodynamic size of 1.83±0.05 µm.
A common compound is revealed by the DLS measure-
ments of the negative control sample solution (no NPs)
and the 0.17 mM low DMAE concentration modified
AuNP solution.
Its appearance in the negative control sample without
AuNPs associates this compound to the solvent medium
impurities. This is seen to correspond to the cytometry
colocalizations observed at the lowest FSC-axis value
projected localized feature at 1.31 FSC. This feature is
detected for the low concentration DMAE (0.17 mM )
sample as well as for the agglomerated control sample.
It turns out to vanish completely for the monodisperse
solution cytometry measurement (1.7 mM DMAE). This
flow-cytometry result corresponds to a compound size
near to the plasmonic resonance at the exciting wave-
length of the FLM device (”A” is associated to a size of
93.5 nm) and of the formed homogeneity of this solution.
Finally it is demonstrated that the AuNP 1.7 mM
DMAE stabilized solution shows a homogenization
in the AuNP particle formation size. The associated
effective size is found to be about 93.5±10.3 nm. This
corresponds to effective sub-dimer formations of the
initial AuNPs (80 nm).
A solvent medium specific scattering background that
is observed for the 0.17 mM DMAE modified sample
6Figure 3. Cytograms of DMAE reduced citrate-capped AuNP solutions: Reactions in the presents of a low DMAE concentration of 0.17
mM . Colocalization plot (a), fluorescence cytograms (b) and of the pure scattering measurement (c).
(Cytometry, see Fig. 3) and for the agglomerated control
sample in the flow-cytometry measurements vanishes
under plasmonic enhancement.
This is due to the homogenization according to a near
resonant effective size of the AuNPs formation in the sta-
bilized 1.7 mM DMAE AuNP solution. The nonspecific
scattering due to cytometry measurement background is
successfully suppressed using the novel approach of vol-
ume fluorescent illumination flow-cytometry diagnostics
presented in this article.
This suppression of ”noise” is seen to be driven by a
change of the spatial characteristic of the fluorescent
emission. This change is based on a direct correlation
of the strongly localized scattering process in presence
of a fluorescent medium. The fluorescence of the solvent
medium is getting directed sideward during the propaga-
tion in the scattering volume of the samples. This pro-
cess is found to be dependent on the diffuse character of
the illumination surrounding the particles on a molecular
scale. A specificity of detection to the sample response
is guaranteed by the spectral separation of the FL emis-
sion in our cytometry measurements. The measurements
demonstrate a proof of principle for this new technique.
B. Simulation of Volume Scattering Light Transport
For a deeper analysis of the underlying processes
simulations of the transport mechanisms in the scatter-
ing sample volume are performed to gain information
on the spatial shift of the sideward scattering. The
proposed volume like behavior of the scattering provides
the key-mechanism to result in a sideward direction
from the cytometry cell that is specific for the scattering
particles.
Thus, the dependence of the sideward component of
the AuNP scattering in the solvent volume is studied
in our model. We compare the volume transport of
the diffuse illumination and the transport of individual
scattering events specific for particle scattering. The
volume scattering is supposed to be separated from the
plasmonic resonance. The light transport calculations
are performed for an (off-resonant) effective size of 1.83
µm of the AuNP compounds, based on our analysis
of the 0.17 mM AuNP solution. The corresponding
optical scattering in a model system is implemented by
using an analytical Volume Scattering Function (VSF)
based on a Henyey-Greenstein (HG) scattering phase
and an anisotropy parameter of g=0.64. This represents
the forward- to backward anisotropy of the scattering
events and is retrieved from MIE calculations. The
scattering coefficient is set to a moderate value of µs
=139.861 1/cm. This corresponds to a concentration
of 3 primary AuNPs (80 nm per cubic-micron). The
volume fluorescence is included as a transport carried
by isotropic (g=0) scattering events. The ”scattering”
coefficient, which is associated to these fluorescence
events, is assumed to be equal to the particle scattering
µs.
In Fig. 4 a, b the spatial characteristics of the volume
fluorescence (g=0) and the fundamental scattering
(g=0.64) are shown. The volume cells are parameterized
by giving a radial axis and a sideward view dimension to
obtain a valid mapping between theory and experiment.
The radial direction is oriented perpendicular to the
incident illumination. The transport dimension in
sideward direction corresponds to the SSC and FL views
of the detection in our flow-cytometry measurements.
A ”measurement” correlated to a sideward collimation
in the cytometry geometry is done by averaging both
maps retrieved from simulation along the radial cell
dimension, (length 1.3 µm), respectively.
Fig. 4 c shows an asymmetry analysis of the 8-bit
representation of the volume light transport simulation.
The data from Fig. 4 a and b are processed according to
7Figure 4. Volume Light Transport simulated maps of the attenua-
tion for g=0 (a) and g=0.64 (b) due to the scattering events, where
Henyey-Greenstein (HG) analytic phase functions are used form-
ing the Volume Scattering Functions (fluorescence, isotrope g0 and
effective particle scattering g64). The scattering coefficient and the
anisotropy parameter g are used as they are retrieved from MIE
calculations. A density of 3 primary AuNPs per cubic micron and
the highest observed agglomerate sizes of about 1830 nm are im-
posed. (c) asymmetry analysis of (a) and (b) following the equation
g0−g64
g0+g64
.
the following equation:
g0 − g64
g0 + g64
(1)
where g0 represents the matrix from Fig. 4 a and g64
the matrix from Fig. 4 b.
The given colorscale supports a direct representation
of the dominating volume transport direction for g0
(orange to white) and g64 (orange to black). One
has to keep in mind that the definition of asymmetry
used here removes any kind of absolute amplitude
values explaining the ring like structures at long radial
distance from zero position. Fig. 4c clearly shows the
stronger attenuation from the agglomerated sample (g64)
comparing the amplitudes from Fig. 4 a and b with
the dominating occurrence of black areas with respect
to the radial dimension. Up to a transport depth of
0,2 µm the g64 contributions are significantly stronger
taking the corresponding amplitude values of (b) into
account. Thus the dimension of the spread along the
axis of illumination is found to depend on the pure
volume fluorescence (g0, white) or the particle volume
scattering (g64, black) in the cell.
Due to volume scattering events the attenuation of the
transport depth is reduced with respect to the pure vol-
ume fluorescence. As a consequence one can clearly see
that a significant decrease of the optical divergence of the
sideward emission from the sample volume. From these
simulations we can demonstrate that a well defined par-
ticle dependent specificity exists even under the assump-
tion of fluorescent illumination in the volume. Experi-
mentally this specificity is supported by a well defined
cone of acceptance given by the objective lens in side-
ward detection direction in the FCM. Furthermore the
widely spread emission of the fluorescent illumination in
the cytometry measurements is associated to this cone of
collimation only when scattering by the AuNPs is taken
into account.
As a consequnce and supported by the simulations a
higher degree of accuracy of the FCM diagnostics in our
novel approach is proposed to be achieved if the numer-
ical aperture of the sideward detecting collimating ob-
jective lens is reduced by an aperture-stop. The radial
dimension of the model cell of 1.3 µm corresponds to a
NA=0.53 for the collimation (x50, WD 0.4 mm). To
optimize the specification of a novel FCM5 diagnostic
under ambient illumination to a broad range of particle
sizes this represents an initial value to match the col-
limation aperture as a key-parameter modifing a FCM
device. Thus further measurements are planned to verify
this proposal in more detail.
IV. CONCLUSIONS
In this article we demonstrate a significant improve-
ment of cytogram feature separation quality by a novel
flow-cytometry diagnostic approach. A diffuse illumina-
tion of the solutions was applied and the analysis revealed
the volume scattering processes to drive the specificity of
the particle scattering events.
The enhancement of the cytogram quality and feature
separation is successfully demonstrated by comparison of
fluorescence FL to fundamental scattering SSC measure-
ments. The volume fluorescence of the solvent medium
provides the illumination in these measurements. Thus
no apparative changes of the utilized conventional FCM
device is needed and the measurement can be performed
by the spectral separation of fluorescence in the sideward
detection pathway of the device.
For initial measurements citrate-capped 80 nm sized
gold nanoparticles were stabilized in aqueous solution by
chemical reduction providing 2-(dimethylamino)ethanol
tertiary amine functionality. Detailed studies of the dis-
persities of the particle sample solutions are performed.
Even under presence of an unspecific scattering back-
ground resulting from the solution, we can demonstrate a
significant enhancement in data quality opening a broad
range of new applications.
The nature of the volume scattering mechanism is stud-
ied in more detail based on Monte-Carlo modeled spread
functions. A reduced divergence in the sideward emission
from the cytometry cell is verified to rely on the specific
scattering events of the particle in solution. The model
provides information to associate this to the cone of op-
tical acceptance of the device in sideward detection.
A variation of the aperture of the FCM detection in this
direction is identified as another key-parameter to fur-
ther optimization of the performance and accuracy in the
scattering compound separation by the flow-cytometry
8approach discussed here.
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